NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Bajaj Healthcare Q3 PAT Rises 34% to ₹15.67 Cr; Key Management Re-appointed
Bajaj Healthcare reported a strong 31.3% YoY growth in revenue from operations, reaching ₹161.22 crore for Q3 FY26. Net profit for the quarter surged by 33.7% YoY to ₹15.67 crore, aided by improved performance in continuing operations and significantly reduced losses from discontinued units. The company also announced the re-appointment of its top leadership, including the Chairman and Managing Directors, for another three-year term starting April 2026. Nine-month performance remains robust with total profit increasing to ₹38.62 crore compared to ₹28.32 crore in the previous year.
முக்கிய அம்சங்கள்
Revenue from operations grew 31.3% YoY to ₹16,122.27 lakhs in Q3 FY26.Net profit for the period increased 33.7% YoY to ₹1,567.38 lakhs.9M FY26 total income reached ₹46,215.16 lakhs compared to ₹39,396.27 lakhs in 9M FY25.Losses from discontinued operations narrowed significantly to ₹42.71 lakhs from ₹324.44 lakhs YoY.Board approved the re-appointment of the core promoter management team for a 3-year term starting April 2026.
👀 கவனிக்க வேண்டியவை
Investors should view the strong top-line and bottom-line growth as a positive sign of operational efficiency and scale. The continuity in leadership provides stability, though investors should monitor the final disposal of discontinued assets.
Bajaj Healthcare Seeks Shareholder Approval for 7 Director Appointments and Re-appointments
Bajaj Healthcare has issued a postal ballot notice to seek shareholder approval for the appointment of three Independent Directors and the re-appointment of four key executive leaders. The executive re-appointments, including the Chairman & Managing Director and Managing Director, are for three-year terms starting April 1, 2026. The three new Independent Directors are proposed for five-year terms to enhance board oversight and governance. Shareholders can cast their votes electronically from January 20 to February 19, 2026.
முக்கிய அம்சங்கள்
Re-appointment of Sajankumar Rameshwarlal Bajaj as CMD for a 3-year term starting April 1, 2026Proposed appointment of 3 new Independent Directors for 5-year terms to strengthen board governanceRe-appointment of Anil Champalal Jain as MD and two other Whole-Time Directors for 3-year termsE-voting period scheduled from January 20, 2026, to February 19, 2026Cut-off date for eligibility to vote is January 16, 2026
👀 கவனிக்க வேண்டியவை
Shareholders should review the profiles of the proposed directors and participate in the e-voting process to ensure leadership stability. Leadership continuity is generally a positive sign for the execution of the company's long-term strategy.
Bajaj Healthcare Q3 FY26: Revenue Up 31%, API Exports Surge 110% YoY
Bajaj Healthcare reported a strong Q3 FY26 with revenue growing 31.3% YoY to Rs. 1,612.2 Mn, primarily driven by a massive 109.8% surge in API exports. EBITDA margins improved slightly to 19.8%, leading to a 33.7% YoY increase in net profit to Rs. 156.7 Mn. The company achieved a significant regulatory milestone as the first Indian firm to receive CDSCO approval for Phase III trials of Suvorexant. For the nine-month period, PAT grew by 36.4%, reflecting sustained momentum in regulated markets and specialty drug development.
முக்கிய அம்சங்கள்
Revenue from operations grew 31.3% YoY to Rs. 1,612.2 Mn in Q3 FY26.API Export revenue more than doubled, growing 109.8% YoY to Rs. 486.8 Mn.EBITDA increased by 34.6% YoY to Rs. 323.3 Mn with margins expanding to 19.8%.Profit for the period (PAT) rose 33.7% YoY to Rs. 156.7 Mn.Filed 9 DMFs during the quarter, bringing the cumulative total to 69 filings.
👀 கவனிக்க வேண்டியவை
The company shows strong momentum in high-margin API exports and a successful transition towards regulated markets. Investors should monitor the progress of Phase III clinical trials for Suvorexant and Cenobamate as these represent high-value specialty opportunities.
Hindware Home Innovation Gets NCLT Nod to Convene Meetings for Business Demerger
Hindware Home Innovation Limited (HHIL) has received an order from NCLT Kolkata to convene meetings for its proposed composite scheme of arrangement. The restructuring involves demerging the consumer product business into HHIL Limited and the remaining business into Hindware Limited, with an appointed date of April 1, 2025. A corrigendum has rescheduled the crucial meeting for 43,059 equity shareholders to March 7, 2026. This move is a significant step toward corporate simplification and potential value unlocking for shareholders.
முக்கிய அம்சங்கள்
NCLT Kolkata directs convening of meetings for a demerger involving three group entities.Consumer product business to be demerged into HHIL Limited; remaining business into Hindware Limited.Meeting for 43,059 equity shareholders and 2,133 unsecured creditors rescheduled to March 7, 2026.Appointed date for the proposed scheme is set as April 1, 2025.Valuation report and fairness opinion completed by EY and Corporate Professionals Capital respectively.
👀 கவனிக்க வேண்டியவை
Investors should monitor the voting results of the shareholder meeting on March 7, 2026, as the demerger is expected to create specialized entities. This restructuring typically leads to better operational focus and market valuation for individual business segments.
Indosolar Reports Robust Q3 FY26 Growth: PAT Surges 305% YoY to ₹41.47 Crores
Indosolar Limited, a subsidiary of Waaree Energies, reported a stellar performance for Q3 FY26 with total income rising 92.20% YoY to ₹199.70 crores. Profitability saw a massive jump as PAT surged 304.98% YoY to ₹41.47 crores, supported by significant margin expansion. EBITDA margins improved from 23.44% to 35.64% during the quarter, reflecting better operational efficiency. For the nine-month period (9M FY26), the company's PAT grew by an exceptional 1288% to ₹204.60 crores compared to the previous year.
முக்கிய அம்சங்கள்
Total Income for Q3 FY26 stood at ₹199.70 crores, up 92.20% from ₹103.90 crores in Q3 FY25.Quarterly PAT increased by 304.98% YoY to ₹41.47 crores with PAT margins doubling to 20.77%.EBITDA for the quarter grew 192.28% YoY to ₹71.17 crores, with margins expanding to 35.64%.9M FY26 performance shows massive scale-up with PAT reaching ₹204.60 crores vs ₹14.74 crores YoY.The company operates a 1.3 GW solar module manufacturing facility in Noida as a Waaree Energies subsidiary.
👀 கவனிக்க வேண்டியவை
Investors should take note of the significant turnaround and margin expansion, which positions the company well in the high-growth solar sector. The strong parentage of Waaree Energies and the 1.3 GW capacity utilization remain key drivers to watch for long-term value.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Indosolar Q3 Net Profit Jumps to ₹41.47 Cr; Appoints Dr. Jignesh Rathod as New CEO
Indosolar Limited reported a stellar performance for Q3 FY26, with revenue from operations nearly doubling to ₹199.53 crore compared to ₹103.01 crore in the previous year. Net profit surged significantly to ₹41.47 crore from ₹10.24 crore in Q3 FY25, reflecting the successful scale-up of its Greater Noida manufacturing facility. The company also announced a leadership change, appointing Dr. Jignesh Rathod as the new CEO following the resignation of Amit Ashok Paithankar. Furthermore, the board has proposed shifting the registered office from Delhi to Maharashtra to better align with Waaree Group operations.
முக்கிய அம்சங்கள்
Revenue from operations grew 93.7% YoY to ₹199.53 crore in Q3 FY26.Net profit for the quarter increased by over 300% YoY to ₹41.47 crore.Nine-month revenue reached ₹596.75 crore, up from ₹130.57 crore in the corresponding period last year.Dr. Jignesh Devchandbhai Rathod appointed as CEO and Non-Executive Director effective January 16, 2026.Board approved shifting the registered office from Delhi to Maharashtra, subject to shareholder approval.
👀 கவனிக்க வேண்டியவை
Investors should view the strong earnings growth and the appointment of a Waaree Group veteran as CEO as a positive signal for operational stability. The stock remains a strong hold as the company continues to benefit from its newly operational manufacturing capacity.
Bajaj Healthcare Re-appoints Top Leadership Team for 3-Year Terms Starting April 2026
Bajaj Healthcare's Board has approved the re-appointment of its core leadership team, including Chairman & MD Sajankumar Bajaj and MD Anil Jain, for three-year terms. These appointments, effective from April 1, 2026, ensure management continuity for the company's API and formulation divisions. Additionally, two Whole-Time Directors, Ms. Namrata Bajaj and Mr. Pakshal Jain, were re-appointed for similar tenures. The board also approved the un-audited financial results for the quarter and nine months ended December 31, 2025, during the same session.
முக்கிய அம்சங்கள்
Re-appointment of Mr. Sajankumar Rameshwarlal Bajaj as Chairman & MD for 3 years effective April 1, 2026.Re-appointment of Mr. Anil Champalal Jain as Managing Director for a 3-year term ending March 31, 2029.Two Whole-Time Directors re-appointed for 3-year tenures to oversee Sales, Marketing, and API development.Board approved un-audited financial results for the quarter and nine months ended December 31, 2025.All leadership extensions are subject to shareholder approval via a forthcoming postal ballot.
👀 கவனிக்க வேண்டியவை
Investors should view these re-appointments as a positive sign of management stability and continuity. The primary focus should now shift to analyzing the Q3 FY26 financial results released in the same meeting.
Waaree Energies Incorporates 8 New Step-Down Subsidiaries for IPP Projects
Waaree Energies Limited has announced the incorporation of eight new wholly-owned step-down subsidiaries through its subsidiary, Waaree Forever Energies Private Limited. These entities are established as Independent Power Producers (IPP) to facilitate and hold specific power projects under the IPP framework. All eight companies were incorporated between January 13 and January 15, 2026, and are 100% owned by the group. This move signals a structured expansion strategy to scale the company's renewable energy project portfolio.
முக்கிய அம்சங்கள்
Incorporation of 8 new wholly-owned step-down subsidiaries under Waaree Forever Energies Private Limited.Entities are categorized as Independent Power Producers (IPP) for specific power projects.All subsidiaries are 100% owned by the group with zero initial turnover as they are newly formed.Incorporation dates for the entities range from January 13, 2026, to January 15, 2026.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step toward expanding the company's project pipeline in the renewable energy sector. Monitor future updates regarding specific project allocations or capital expenditure plans for these new subsidiaries.
Waaree RTL 9M FY26 Revenue Hits ₹2,229 Cr; Order Book Stands at 2.9 GWp
Waaree Renewable Technologies Limited (WAAREERTL) has reported a stellar performance for 9M FY26, with revenue reaching ₹2,229 crore, significantly surpassing the full-year FY25 revenue of ₹1,598 crore. The company maintains a massive execution pipeline of 2,922 MWp, including a landmark 2,012 MWp project for Jindal Renewables. With an asset-light business model, the firm achieved an exceptional ROE of 65.29% and ROCE of 61.94% in FY25. The company is strategically positioned to capitalize on India's 2030 solar targets through its integrated relationship with parent company Waaree Energies.
முக்கிய அம்சங்கள்
9M FY26 revenue reached ₹2,229 crore, already exceeding the total FY25 revenue of ₹1,598 crore.Current unexecuted order book stands at a robust 2,922 MWp as of Q3 FY26.Total commissioned capacity has reached 4.56 GWp, with an additional O&M portfolio of ~1,180 MWp.Major ongoing projects include a 2,012 MWp site in Bikaner and a 1,000 MWp site in Solapur.Maintained high profitability metrics with an FY25 EBITDA margin of 19.46% and PAT margin of 14.33%.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's ability to execute its 2.9 GWp order book on schedule, which is the primary driver for near-term valuation. The stock remains a high-growth play in the renewable EPC space given its superior return ratios and strong parentage.
Waaree Renewable Q3 FY26 PAT Jumps 125% YoY to Rs 120 Cr; Revenue up 136%
Waaree Renewable Technologies reported a stellar Q3 FY26 with revenue surging 136.18% YoY to Rs 851.06 crore. Net profit (PAT) grew by 124.74% YoY to Rs 120.19 crore, while EBITDA rose 120.79% to Rs 158.80 crore. The company maintains a strong unexecuted order book of 2.92 GWp to be executed over the next 12-15 months. Additionally, the board approved a new capex for a 120 MWp Solar Power Park in Maharashtra, indicating continued expansion.
முக்கிய அம்சங்கள்
Q3 FY26 Revenue grew 136.18% YoY to Rs 851.06 Cr; 9M FY26 Revenue reached Rs 2,229.03 Cr.PAT for Q3 FY26 increased by 124.74% YoY to Rs 120.19 Cr with a margin of 14.12%.Unexecuted order book stands at a robust 2.92 GWp with a massive bidding pipeline of ~29 GWp.EBITDA for 9M FY26 grew 135.29% YoY to Rs 434.28 Cr with margins at 19.48%.Board approved capex for setting up a 120 MWp Solar Power Park in Buldhana, Maharashtra.
👀 கவனிக்க வேண்டியவை
Investors should note the company's exceptional execution pace and high revenue visibility provided by the 2.92 GWp order book. The stock remains a key play in the Indian solar EPC segment, though one should monitor margin sustainability as the company scales.
Share India Securities Receives CRISIL A1+ Rating for Rs 250 Crore Commercial Papers
CRISIL Ratings Limited has assigned its highest short-term rating of 'CRISIL A1+' to Share India Securities Limited's proposed Commercial Paper program. The rating covers a total amount of Rs 250 Crore, indicating a very strong degree of safety regarding the timely payment of financial obligations. This high credit rating is expected to help the company raise short-term capital at competitive interest rates. The assignment of this rating is a crucial step for the company to diversify its funding sources and support its operational liquidity.
முக்கிய அம்சங்கள்
CRISIL Ratings assigned a 'CRISIL A1+' rating to the proposed Commercial Paper program.The total value of the rated Commercial Papers is Rs 250 Crore.The 'A1+' rating is the highest possible short-term credit rating, signifying the lowest credit risk.The rating letter was officially received by the company on January 13, 2026.
👀 கவனிக்க வேண்டியவை
Investors should view this as a validation of the company's strong credit profile and liquidity position. The ability to raise funds at lower costs through Commercial Papers could potentially improve margins in its financial services business.
Waaree Renewable Bags INR 102.75 Crore Solar EPC Order for 35 MWp Project
Waaree Renewable Technologies Limited has secured a Letter of Award for a 25 MWac/35 MWp ground-mounted solar power project on a turnkey basis. The contract is valued at approximately INR 102.75 crore excluding taxes and includes the development of 50MW evacuation infrastructure. The order was awarded by a major domestic manufacturer of pig iron and castings. The project is scheduled for completion during the financial year 2026-27, providing significant revenue visibility for the company.
முக்கிய அம்சங்கள்
Total order value of approximately INR 102.75 Crore excluding taxesProject capacity of 25 MWac / 35 MWp with 50MW evacuation infrastructureTurnkey EPC execution for a major domestic industrial clientScheduled for completion during the financial year 2026-27
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development that strengthens the company's order book and revenue visibility for FY27. Monitor the company's execution efficiency and margin maintenance in the solar EPC segment.
Waaree Renewable Credit Rating Upgraded to IND A/Stable from IND A-
India Ratings has upgraded Waaree Renewable Technologies Limited's credit rating for its bank loan facilities to 'IND A' from 'IND A-' with a Stable outlook. The total rated bank loan amount has been reduced from INR 289.40 million to INR 258.00 million. This upgrade signifies the company's improving financial profile and enhanced creditworthiness. The facilities are specifically associated with the Indian Renewable Energy Development Agency Limited (IREDA).
முக்கிய அம்சங்கள்
Credit rating upgraded to IND A/Stable from IND A- by India Ratings (Ind-Ra).Total rated bank loan facilities reduced to INR 258.00 million from INR 289.40 million.The upgrade applies to term loans provided by the Indian Renewable Energy Development Agency Limited (IREDA).The 'Stable' outlook indicates the agency's expectation of consistent financial performance in the medium term.
👀 கவனிக்க வேண்டியவை
The rating upgrade is a positive signal of the company's strengthening balance sheet and could potentially lead to lower interest costs. Investors should view this as a validation of the company's operational stability and financial health.
Waaree Energies Bags 105 MW Solar Module Supply Order for FY 2025-26
Waaree Energies Limited has secured a domestic order for the supply of 105 MW solar modules from a prominent Indian renewable power developer. The contract is a one-time order and is scheduled for completion within the Financial Year 2025-26. This win reinforces the company's market position and provides clear revenue visibility for the upcoming fiscal period. The transaction involves no related party interests, ensuring a standard commercial engagement.
முக்கிய அம்சங்கள்
Received order for the supply of 105 MW solar modulesContract awarded by a renowned domestic renewable power project developerSupply completion timeline set within the Financial Year 2025-26One-time contract with no promoter or related party involvement
👀 கவனிக்க வேண்டியவை
This order strengthens the company's near-term revenue outlook; investors should monitor execution efficiency and the impact on profit margins.
Waaree Renewable Technologies Revises Order Value Downward to INR 1,039.60 Crore
Waaree Renewable Technologies Limited (WAAREERTL) has announced a downward revision of a project capacity originally awarded in September 2025. The project capacity has been reduced from 870 MWac to 704 MWac due to evacuation considerations and technical optimization. This results in a contract value reduction of INR 212.83 Crore, bringing the total order value to INR 1,039.60 Crore. The project remains scheduled for completion within the financial year 2026-27.
முக்கிய அம்சங்கள்
Revised project capacity stands at 704 MWac / 1,000 MWp, down from the original 870 MWac / 1,218 MWp.Total contract value decreased by INR 212.83 Crore to a revised amount of INR 1,039.60 Crore.Revision is attributed to evacuation considerations and optimization of DC overloading.The project is a related party transaction with Waaree Forever Energies Private Limited.Execution timeline remains unchanged with completion targeted for FY 2026-27.
👀 கவனிக்க வேண்டியவை
Investors should account for the ~17% reduction in this specific contract's revenue contribution while noting that the remaining order value of over INR 1,000 Crore remains significant for the company's FY27 outlook.
Share India Securities Incorporates New Subsidiary Share India Cred Capital
Share India Securities Limited has announced the successful incorporation of its new subsidiary, Share India Cred Capital Private Limited, on January 06, 2026. This follows the board's initial approval on October 30, 2025, for a new entity originally proposed as Share India Greyhill Private Limited. The subsidiary is registered with the Registrar of Companies, Kanpur, and represents a step in the company's organizational expansion. While the specific business vertical for this subsidiary wasn't detailed in this filing, it aligns with the group's broader financial services footprint.
முக்கிய அம்சங்கள்
Subsidiary Share India Cred Capital Private Limited incorporated on January 06, 2026Follows initial Board approval granted on October 30, 2025Registered with the Registrar of Companies, Kanpur, under CIN U64990UP2026PTC240582Name changed from the previously proposed Share India Greyhill Private Limited
👀 கவனிக்க வேண்டியவை
Investors should watch for future disclosures regarding the specific business operations and capital allocation for this new subsidiary. The move indicates ongoing corporate expansion, though immediate impact on the bottom line is expected to be neutral.
MT Educare Reports ₹32.33 Crore Total Indebtedness Amid Ongoing Insolvency Process
MT Educare Limited has disclosed a total financial indebtedness of ₹32.33 Crores as of December 31, 2025. The company continues to operate under the Corporate Insolvency Resolution Process (CIRP) initiated in December 2022 due to defaults triggered by pandemic-related disruptions. Beyond direct debt, the company faces invoked corporate guarantees totaling approximately ₹23.99 Crores from Axis Bank and Asset Care & Reconstruction Enterprise. A significant legal dispute involving a ₹49.72 Crore claim by SVC Bank is currently pending before the NCLAT.
முக்கிய அம்சங்கள்
Total financial indebtedness including loans and revolving facilities stands at ₹32.33 Crores.Invoked corporate guarantees include ₹7.3 Crores for Sri Gayatri Education Society and ₹16.69 Crores for Lakshya Forum.The company has been under Corporate Insolvency Resolution Process (CIRP) since December 16, 2022.A ₹49.72 Crore claim by Shamrao Vithal Co-op Bank remains under appeal in NCLAT after being rejected by NCLT.Current debt is primarily managed by Prudent ARC Limited following a debt assignment in August 2023.
👀 கவனிக்க வேண்டியவை
Investors should remain highly cautious as the company is in insolvency proceedings, which typically poses a high risk of equity wipe-out or significant dilution. Avoid new positions until a clear resolution plan is approved by the NCLT.
Waaree Energies Clarifies Rs 1,003 Crore Fundraise by Storage Solutions Unit
Waaree Energies Limited has officially clarified news reports regarding a Rs 1,003 crore fundraise by its entity, Waaree Energy Storage Solutions. The company confirmed that the press release regarding this capital infusion was disclosed to the stock exchanges on January 05, 2026. Management stated that there is no pending unpublished price-sensitive information (UPSI) and that the recent share price movement is market-driven. This fundraise marks a significant capital event for the group's expansion into the energy storage sector.
முக்கிய அம்சங்கள்
Waaree Energy Storage Solutions has raised a total of Rs 1,003 crore as per the verified news item.Company confirms all regulatory disclosures under Regulation 30 have been complied with as of January 05, 2026.Management clarified that no unpublished price-sensitive information (UPSI) is currently pending disclosure.The fundraise highlights the group's aggressive growth strategy in the renewable energy storage market.
👀 கவனிக்க வேண்டியவை
Investors should view the successful Rs 1,003 crore fundraise as a strong indicator of the group's ability to attract capital for its storage business. Monitor the deployment of these funds and their impact on the company's consolidated growth trajectory.
Waaree Energy Storage Solutions (WESSPL), a subsidiary of Waaree Energies, has successfully raised approximately INR 1,003 Crores from strategic investors and HNIs. The funds are earmarked for the development of a 20 GWh advanced lithium-ion cell and battery pack manufacturing facility. This project is part of a larger INR 10,000 Crores capital expenditure plan aimed at making the group a fully integrated energy transition player. The expansion will cater to high-growth sectors including electric mobility, utility-scale storage, and distributed energy applications.
முக்கிய அம்சங்கள்
Raised ~INR 1,003 Crores from family offices, HNIs, and institutional investors.Funding supports the establishment of a 20 GWh lithium-ion cell and battery pack facility.Project is part of a total announced Capex of ~INR 10,000 Crores for energy storage.Aims to provide end-to-end solutions across solar modules, inverters, and battery systems.Facility will focus on high-performance cells for electric mobility and grid stability.
👀 கவனிக்க வேண்டியவை
Investors should view this as a major milestone in Waaree's transition to an integrated green energy giant. Monitor the execution of the 20 GWh facility as it represents a significant portion of the company's long-term growth strategy.
Thyrocare Appoints Industry Veteran Rajdeep Panwar as Chief Commercial Officer
Thyrocare Technologies has appointed Mr. Rajdeep Panwar as its Chief Commercial Officer, effective January 05, 2026. Mr. Panwar brings over 21 years of deep industry experience, having held leadership roles at major diagnostic players including Dr. Lal PathLabs, Apollo Diagnostics, and Medanta Labs. His expertise in P&L management and laboratory network expansion is expected to drive the company's commercial growth and market penetration. This appointment strengthens the senior management team as the company looks to scale its diagnostic operations across India.
முக்கிய அம்சங்கள்
Appointment of Mr. Rajdeep Panwar as Chief Commercial Officer effective January 05, 2026Mr. Panwar brings over 21 years of experience in healthcare and diagnostics industry leadershipPrevious experience includes Director at Medanta Labs and roles at Apollo Diagnostics and Dr. Lal PathLabsExpertise spans P&L management, digital diagnostics, and large-scale laboratory network expansionThe appointment was approved by the Board via circular resolution on January 05, 2026
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step in strengthening Thyrocare's commercial leadership; monitor for improvements in market share and network expansion in upcoming quarters.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
